Skip to main content

Table 1 Demographic and laboratory characteristics of study populationa

From: Leucine disposal rate for assessment of amino acid metabolism in maintenance hemodialysis patients

  Hemodialysis
(n = 35)
Control
(n = 17)
P
Age,b y 49 ± 15 45 ± 11 0.25
Race, n (%)
 African American 28 (80) 11 (65)  
 Caucasian 7 (20) 6 (35) 0.23
Male sex, n (%) 28 (80) 13 (76) 0.77
Primary Disorder of ESRD, n (%)
 Hypertension 14 (40)   
 Diabetes Mellitus 7 (20)   
 Glomerulonephritis 7 (20)   
 RCC Bilateral Nephrectomy 1 (3) NA
 Polycystic Kidney Disease 1 (3)   
 Other 5 (14)   
Dialysis Vintage,c months 34 (17, 120)   NA
Body Composition
 BMI,b kg/m2 29 ± 6 28 ± 7 0.34
 Truncal Fat,b % 38 ± 13 33 ± 12 0.09
 Fat Mass,c kg 30 (23, 37) 24 (15, 31) 0.21
 Lean Mass,c kg 52 (49, 61) 59 (47, 66) 0.34
BUN,b mg/dL 45 ± 16 13 ± 3 <0.001
Creatinine,b mg/dL 9.7 ± 2.9 0.9 ± 0.1 <0.001
Albumin,b g/dL 3.9 ± 0.4 4.0 ± 0.2 0.34
hs-CRP,c mg/L 4.0 (1.8, 10.6) 0.9 (0.4, 3.1) <0.001
Hematocrit,b % 37 ± 5 43 ± 3 <0.001
Fasting Glucose,b mg/dL 98 ± 17 105 ± 23 0.11
Baseline Insulin,c μU/mL 12.6 (10.7, 19.8) 10.4 (5.2, 13.3) 0.05
HbA1c,b % 5.2 ± 0.6 5.3 ± 0.5 0.33
HOMA-IR,c 2.9 (2.2, 4.4) 2.7 (1.1, 3.5) 0.17
  1. a BUN blood urea nitrogen, ESRD end stage renal disease, HbA1c hemoglobin A1c, hs-CRP high-sensitivity C-reactive protein, HOMA-IR homeostatic model assessment of insulin resistance, RCC renal cell carcinoma
  2. bMean ± SD
  3. cMedian (IQR)